Webinar Series
Pressure to holistically and systematically address sustainability is mounting across the business world, and our pharmaceutical industry is no exception. Environmental, economic, and social sustainability are all gaining prominence in corporate strategy at drug makers and, in turn, their suppliers and sub-suppliers alike. Blueprints for sustainability by design (SbD), all the way to the product level, are increasingly appearing in industry publications and being used by early adopters to identify opportunities (and relative efforts) to start delivering improvements.
So how can the pharmaceutical industry reduce its impact on the environment and promote sustainable development? Our ongoing webinar series covers a wide range of topics.
- Webinar 1: Introduction in to sustainability in Pharma
- Webinar 2: Critical Utilities
- Webinar 3: Clean by Design
- Webinar 4: Carbon Footprint
Are you interested? Register below.
Did you miss any of the live webinars? No need to worry, you can still watch them on demand.
Next webinar
When: January 16th
How a pharmaceutical company can get aware of the scope 3 emissions impact caused by the fill & finish equipment ? A product carbon footprint calculation of a machine already in production
Watch it on demand or register for the next live event
On-Demand: Introduction to Sustainability in Pharma
Pressure to holistically and systematically address sustainability is mounting across the business world, and our pharmaceutical industry is no exception. Environmental, economic, and social sustainability are all gaining prominence in corporate strategy at drug makers and, in turn, their suppliers and sub-suppliers alike.On-Demand: Critical Utilities
This webinar, the second in a series on sustainability, tackles sustainability in (bio-)pharmaceutical critical utilities. Join our subject matter expert Christian Lavarreda on this second installment of "Sustainability in Pharma".On-demand: Clean by Design
Can multiuse stainless steel “dinosaurs” finally evolve, or will the single-use "meteorites" make them extinct?
Multi-use vs. single-use comparisons inevitably revolve around CAPEX, OPEX, speed-to-market, supply resiliency, and sustainability.
Live: Carbon Footprint in Pharma
How a pharmaceutical company can get aware of the scope 3 emissions impact caused by the fill & finish equipment ? A product carbon footprint calculation of a machine already in production
In the realm of sustainability and pharmaceutical innovation, two distinct narratives converge.